Healthcare & Life Sciences
Renova Therapeutics
United Statesrenovatherapeutics.com/about/overview
series-c-plus
series-c-plus
Stage
1
Investors
About
Renova Therapeutics develops gene therapies aimed at treating chronic cardiovascular and metabolic diseases, including congestive heart failure and type 2 diabetes, by leveraging proprietary gene therapy platforms.
Explore Renova Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.